These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

757 related items for PubMed ID: 22414872

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 4. Erythropoietins: a common mechanism of action.
    Elliott S, Pham E, Macdougall IC.
    Exp Hematol; 2008 Dec; 36(12):1573-84. PubMed ID: 18922615
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin.
    Dunlop EA, Percy MJ, Boland MP, Maxwell AP, Lappin TR.
    Neurodegener Dis; 2006 Dec; 3(1-2):94-100. PubMed ID: 16909043
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pleiotropic effects of erythropoietin].
    Kes P, Basić-Jukić N, Furić-Cunko V.
    Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
    Divoky V, Song J, Horvathova M, Kralova B, Votavova H, Prchal JT, Yoon D.
    J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression.
    Hedley BD, Allan AL, Xenocostas A.
    Clin Cancer Res; 2011 Oct 15; 17(20):6373-80. PubMed ID: 21750199
    [Abstract] [Full Text] [Related]

  • 18. Lack of expression and function of erythropoietin receptors in the kidney.
    Elliott S, Busse L, Swift S, McCaffery I, Rossi J, Kassner P, Begley CG.
    Nephrol Dial Transplant; 2012 Jul 15; 27(7):2733-45. PubMed ID: 22167585
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
    Trkulja V.
    Med Hypotheses; 2012 Jan 15; 78(1):157-61. PubMed ID: 22078846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.